Matthew Pauls, CEO: Savara SVRA Sell · Filed 24/12/16

Trade details

Type: Insider sale
Amount: $181,063.62
Shares · price: 54,702 sh · $3.31 a share
Held after: 1,536,379 sh
Stock: Savara SVRA
Person: Matthew PaulsCEO
Trade date: 24/12/16
Filed: 24/12/16
Days to filing: 0 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Savara trades, last 26 weeks

What else happened in Savara around then

Filed or reported within 30 days of the trade day · 24/11/16~25/01/15

Matthew Pauls's recent trades

Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$7,925
371 sh
$7,925
Filed 04/06
Traded 04/02
Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$8,516
415 sh
$8,516
Filed 04/06
Traded 04/02
Matthew PaulsDirector
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$424.8K
5,937 sh
$424.8K
Filed 25/03/31
Traded 25/03/28
Matthew PaulsCEO
SellSavara
Sell
Savara
SVRA
$395.6K
84,000 sh
$395.6K
Filed 23/12/29
Traded 23/12/28